MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

915 articles published

RENUKA
RENUKA
1 min read
Market Updates Corporate announcement

Shree Renuka Sugars (RENUKA): Company Update

Company Update Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article
ECOSMOBLTY
ECOSMOBLTY
1 min read
Market Updates Corporate announcement

ECOS (India) Mobility & Hospitality (ECOSMOBLTY): Board Meeting

Board Meeting 1. Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, we submit herewith: a) the Auditor's Report on Standalone & Consolidated Financial Results issued by our Statutory Auditors M/s SS Kothari Mehta & Co. LLP, Chartered Accounts b) Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026 c) Audited Statement of Assets and Liabilities as on March 31, 2026 d)

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article
WESTLIFE
WESTLIFE
1 min read
Market Updates BSE filings

Westlife Foodworld Announces McDonald's 'Let's Family at McD' Campaign for 30 Years

Westlife Foodworld Limited informs BSE about McDonald's India (W&S) unveiling a new brand campaign 'Let's Family at McD' to celebrate 30 years in India.

Read article
INFOBEAN
INFOBEAN
1 min read
Market Updates BSE filings

Infobeans Technologies Achieves ISO 42001:2023 Certification

Infobeans Technologies Ltd. (INFOBEAN) has achieved ISO 42001:2023 certification, as announced in a BSE filing. The company update is marked positive.

Read article
KSHITIJPOL
KSHITIJPOL
1 min read
Market Updates Chartink scans

Kshitij Polyline Surges 5% on Unusual Volume Spurt

Kshitij Polyline (KSHITIJPOL) jumped 4.97% to ₹5.70 on heavy volume of 5.12 million shares, flagging unusual trading activity. Investors should evaluate fundamentals before acting.

Read article
TCIEXP
TCIEXP
1 min read
Market Updates Corporate announcement

TCI Express Releases Q4/FY 2025-26 Investor Presentation on BSE

TCI Express has made its Q4/FY 2025-26 investor presentation available through BSE, offering stakeholders insight into the company's latest quarterly performance and financial positioning.

Read article
TCIEXP
TCIEXP
1 min read
Market Updates Corporate announcement

TCI Express Q4 FY 2025-26 Investor Presentation Published on BSE

TCI Express has published its Q4/FY 2025-26 investor presentation on BSE, offering stakeholders a detailed overview of the company's quarterly performance and financial position.

Read article
SWRNASE
SWRNASE
1 min read
Market Updates BSE filings

Swarna Securities (SWRNASE) Intimates Q4 & FY2026 Results to BSE

Swarna Securities informs BSE that Q4 and FY2026 audited results have been published. Full filing details available on ztox.in.

Read article
GPPL
GPPL
1 min read
Market Updates Corporate announcement

Gujarat Pipavav Port Files Investor Presentation with NSE

Gujarat Pipavav Port Limited has informed the NSE about filing an investor presentation, providing stakeholders with updates on company performance and strategy.

Read article
CEIGALL
CEIGALL
1 min read
Market Updates NSE filings

Ceigall India Signs Pact with Neo Infra Fund for CMASH Divestment

Ceigall India has entered into a definitive agreement with Neo Infra Fund for divesting its CMASH segment. The transaction was disclosed via NSE filing on June 4, 2026.

Read article
CEIGALL
CEIGALL
1 min read
Market Updates BSE filings

Ceigall India Signs Definitive Pact with Neo Infra Fund for CMASH Divestment

Ceigall India has signed a definitive agreement with Neo Infra Fund to divest its CMASH business, continuing from an earlier letter dated June 4, 2026.

Read article

Track Indian stocks with ZTOX AI

Get started free

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Insider Deals Alert
Volume Breakouts
Block Deal Notifications
Preferential Issue Alerts
Free ₹0
Basic ₹89/mo
Advanced ₹119/mo
No credit card required to start on the free plan.
Start Free Now